Work

Early response patterns on omalizumab predict long‐term outcomes in chronic spontaneous urticaria

Year: 2025

Type: article

Abstract: Data can be made available upon reasonable request, in compliance with Danish legislation.

Source: Journal of the European Academy of Dermatology and Venereology

DOI: 10.1111/jdv.70158

Authors: Ditte Georgina Zhang, Mia‐Louise Nielsen, Jennifer Astrup Sørensen, Somaia Naassan, Nadja Højgaard Pedersen, Clara Emilie Syrene Østergaard, Christian Vestergaard, Zarqa Ali, Jacob P. Thyssen, Alexander Egeberg, Simon Francis Thomsen

Institutions: Frederiksberg Hospital, Bispebjerg Hospital, Copenhagen University Hospital, Aarhus University Hospital, University of Copenhagen

Language: English

Topic: Urticaria and Related Conditions

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, National Psoriasis Foundation, Eli Lilly and Company, Pfizer, Sanofi, Regeneron Pharmaceuticals, Simon Spies Fonden, LEO Pharma, Janssen Pharmaceuticals

OpenAlex ID: W4416143394

FWCI: 0.623

Cites: 4

Cited by: 1

Related to: